Filing Details

Accession Number:
0001209191-14-025808
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-03 20:01:30
Reporting Period:
2014-04-01
Filing Date:
2014-04-03
Accepted Time:
2014-04-03 20:01:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Biosciences Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343543 D Philip Gregory C/O Sangamo Biosciences Inc.,
Point Richmond Tech Cntr, 501 Canal Blvd
Richmond CA 94804
Sr. Vp Res. & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-04-01 3,000 $6.82 112,347 No 4 M Direct
Common Stock Acquisiton 2014-04-01 4,000 $13.98 116,347 No 4 M Direct
Common Stock Acquisiton 2014-04-01 3,000 $3.45 119,347 No 4 M Direct
Common Stock Acquisiton 2014-04-01 5,000 $5.35 124,347 No 4 M Direct
Common Stock Disposition 2014-04-01 15,000 $17.80 109,347 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-04-01 3,000 $0.00 3,000 $6.82
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-04-01 4,000 $0.00 4,000 $13.98
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-04-01 3,000 $0.00 3,000 $3.45
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-04-01 5,000 $0.00 5,000 $5.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,000 2016-12-12 No 4 M Direct
82,000 2017-12-11 No 4 M Direct
58,500 2018-12-09 No 4 M Direct
90,000 2019-12-06 No 4 M Direct
Footnotes
  1. Includes 33,333 shares, 26,666 shares, and 35,000 shares subject to restricted stock units granted on December 8, 2011, December 6, 2012, and December 12, 2013 respectively, which will be issued as such units vest in accordance with their terms.
  2. The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014.
  3. All shares underlying this option are vested and immediately exercisable.